Additionally, in hepatocellular carcinoma (HCC), a dominant m.2356C>G clone correlated with POLR2A activation and widespread transcriptional amplification, consistent with a mitochondria-nucleus signaling axis contributing to adverse prognosis in this cancer type. This evidence concerns the gene POLR2A and hepatocellular carcinoma.